5mg ghk cu GHK-Cu (20 mg) 5 vials – customsupplements GHK Cu Peptides for Research

Preclinical and clinical studies have demonstrated its efficacy in reducing body weight both as a monotherapy and in combination with GLP-1 receptor agonists such as semaglutide, highlighting its potential as a next-generation therapeutic agent for obesity and metabolic syndrome management

Thats why we publish Certificate of Analysis (COA) reports for each batch we produce showcasing purity, potency, and safety

A: Peptides are short chains of amino acids that signal your body to perform specific functions like burning fat, increasing energy, or healing tissue

First isolated by biochemist Loren Pickart in 1973 from human plasma albumin, GHK-Cu has since been identified in human saliva, urine, and various tissue types

International journal of molecular sciences , 19 (7), 1987